WuXi AppTec (OTCMKTS:WUXAY) Hits New 1-Year High – Here’s Why

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $19.72 and last traded at $19.72, with a volume of 1218 shares. The stock had previously closed at $19.60.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, WuXi AppTec presently has an average rating of “Moderate Buy”.

WuXi AppTec Trading Up 0.6%

The business has a 50-day simple moving average of $16.67 and a 200-day simple moving average of $15.24.

WuXi AppTec (OTCMKTS:WUXAY) last posted its quarterly earnings data on Monday, April 27th. The company reported $0.23 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The business had revenue of $1.82 billion during the quarter, compared to analysts’ expectations of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.